Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Depreciation and Depletion (2021 - 2025)

Kezar Life Sciences' Depreciation and Depletion history spans 5 years, with the latest figure at $200000.0 for Q3 2025.

  • For Q3 2025, Depreciation and Depletion changed 0.0% year-over-year to $200000.0; the TTM value through Sep 2025 reached $900000.0, down 18.18%, while the annual FY2024 figure was $1.0 million, 9.09% down from the prior year.
  • Depreciation and Depletion for Q3 2025 was $200000.0 at Kezar Life Sciences, roughly flat from $200000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $300000.0 in Q2 2021 and bottomed at $200000.0 in Q1 2021.
  • The 5-year median for Depreciation and Depletion is $200000.0 (2021), against an average of $247368.4.
  • The largest YoY upside for Depreciation and Depletion was 50.0% in 2022 against a maximum downside of 33.33% in 2022.
  • A 5-year view of Depreciation and Depletion shows it stood at $200000.0 in 2021, then changed by 0.0% to $200000.0 in 2022, then soared by 50.0% to $300000.0 in 2023, then tumbled by 33.33% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Depreciation and Depletion are $200000.0 (Q3 2025), $200000.0 (Q2 2025), and $300000.0 (Q1 2025).